Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-04-05
2011-04-05
Kumar, Shailendra (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S558000, C514S563000, C514S620000
Reexamination Certificate
active
07919529
ABSTRACT:
Disclosed are δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compounds of formula (I)and the salts thereof, having renin-inhibiting properties. Also disclosed are pharmaceutical compositions comprising these compounds and methods of administering them for the treatment of hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, unstable coronary syndrome, diastolic dysfunction, chronic kidney disease, hepatic fibrosis, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty, raised intra-ocular pressure, glaucoma, abnormal vascular growth, hyperaldosteronism, cognitive impairment, alzheimers, dementia, anxiety states and cognitive disorders.
REFERENCES:
patent: 5559111 (1996-09-01), Goschke et al.
patent: 5606078 (1997-02-01), Goschke et al.
patent: 5627182 (1997-05-01), Goschke et al.
patent: 5646143 (1997-07-01), Goschke et al.
patent: 5705658 (1998-01-01), Goschke et al.
patent: 02/40007 (2002-05-01), None
patent: 03/103653 (2003-12-01), None
Wood et al, Biochemical and Biophysical Research Communications 308, pp. 698-705, Structure-based design of aliskiren, a novel orally effective rennin inhibitor. (2003).
Goeschke et al. Bioorganic 8 Medicinal Chemistry Letters, vol. 7, No. 21, pp. 2735-2740, Design and Synthesis of Novel 2.7-Dialkyl. Substituted 5(S)-Amino-4(S)-H˜y˜˜-8-Phenyl-Octanecarboxamides as in Vitro Potent Peptidomeimetic inhibitors of Human Renin. (1997).
Rahuel et al, Chemistry & Biology, 2000, vol. 7, pp. 493-504.
Baeschlin Daniel Kaspar
Maibaum Juergen Klaus
Sellner Holger
Cross Sophie Binet
Kumar Shailendra
Novartis AG
LandOfFree
δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2634630